Company intelligence / Profile preview

NUA Biological

Spain

Ownership: Private
Development stage: Other

Overview

NUA Biological was the world’s first company to develop and distribute highly purified, concentrated marine omega-3 fatty acid supplements, including NuaDHA® and NuaEPA®, providing over 1,000 mg per softgel. NUA also pioneers in antioxidant supplement development and conducts clinical research in partnership with Spanish public and private medical institutions.

Therapeutic areas: CardiovascularNeurologyOther
Modalities: Small moleculeLipid-based nutrition
Industry: Food & Nutrition

Partnerships

Clinical research projects with public and private Spanish medical institutions

Beyond the preview

Go deeper on NUA Biological.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NUA Biological.

Explore the full profile